Clinical Trials Directory

Trials / Completed

CompletedNCT00916838

Neurocognitive Impact of Hypoglycemia in Type 1 Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
187 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
4 Years – 16 Years
Healthy volunteers
Accepted

Summary

125 children with Type 1 Diabetes mellitis (T1DM) between 4 and 16 were recruited and 62 healthy siblings also enrolled in the study. Children with T1DM and sibling controls ages 4 to 16 were assessed on memory and executive control skills at entry to the study (Test 1) and after two years of close monitoring for blood sugar events (Test 2). Diabetic children have their blood sugar tested directly before and after cognitive testing to ensure their blood sugar is within range during the testing. The 2-year follow-up period involves parents/child reporting any severe diabetic episode and periodically providing the results of the diabetic child's usual blood tests from their glucose monitoring device. Children 7 and older also underwent high resolution MRI scans.

Conditions

Timeline

Start date
2003-01-01
Primary completion
2006-03-01
Completion
2017-02-01
First posted
2009-06-10
Last updated
2018-06-18

Source: ClinicalTrials.gov record NCT00916838. Inclusion in this directory is not an endorsement.

Neurocognitive Impact of Hypoglycemia in Type 1 Diabetes (NCT00916838) · Clinical Trials Directory